医疗人力资源解决方案提供商Cross Country Healthcare Inc (CCRN) 即将被私募股权公司Knox Lane以全现金交易方式收购。根据协议条款，Knox Lane将为每股Cross Country Healthcare股票支付13.25美元，整个交易估值约为4.37亿美元。
此次收购价格较Cross Country Healthcare近期股价呈现显著溢价，体现了Knox Lane对该医疗人力资源企业长期价值和发展潜力的高度认可。全现金交易方式将为Cross Country Healthcare股东提供即时的价值变现和确定性收益。
交易完成后，Cross Country Healthcare将成为Knox Lane旗下的私人控股公司，其股票将不再于纳斯达克交易所公开交易。该交易尚需获得Cross Country Healthcare股东批准以及符合惯例成交条件，预计将于2024年下半年完成。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.